Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A Randomized Study Comparing Digital Imaging to Traditional Glass Slide Microscopy for Breast Biopsy and Cancer Diagnosis.

Elmore JG, Longton GM, Pepe MS, Carney PA, Nelson HD, Allison KH, Geller BM, Onega T, Tosteson AN, Mercan E, Shapiro LG, Brunyé TT, Morgan TR, Weaver DL.

J Pathol Inform. 2017 Mar 10;8:12. doi: 10.4103/2153-3539.201920. eCollection 2017.

2.

Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study.

Elmore JG, Tosteson AN, Pepe MS, Longton GM, Nelson HD, Geller B, Carney PA, Onega T, Allison KH, Jackson SL, Weaver DL.

BMJ. 2016 Jun 22;353:i3069. doi: 10.1136/bmj.i3069.

3.

Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective.

Elmore JG, Nelson HD, Pepe MS, Longton GM, Tosteson AN, Geller B, Onega T, Carney PA, Jackson SL, Allison KH, Weaver DL.

Ann Intern Med. 2016 May 17;164(10):649-55. doi: 10.7326/M15-0964. Epub 2016 Mar 22.

4.

Diagnostic concordance among pathologists interpreting breast biopsy specimens.

Elmore JG, Longton GM, Carney PA, Geller BM, Onega T, Tosteson AN, Nelson HD, Pepe MS, Allison KH, Schnitt SJ, O'Malley FP, Weaver DL.

JAMA. 2015 Mar 17;313(11):1122-32. doi: 10.1001/jama.2015.1405.

5.

Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease.

Marks JR, Anderson KS, Engstrom P, Godwin AK, Esserman LJ, Longton G, Iversen ES, Mathew A, Patriotis C, Pepe MS.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):435-41. doi: 10.1158/1055-9965.EPI-14-1178. Epub 2014 Dec 3.

6.

A framework for evaluating diagnostic discordance in pathology discovered during research studies.

Feng S, Weaver DL, Carney PA, Reisch LM, Geller BM, Goodwin A, Rendi MH, Onega T, Allison KH, Tosteson AN, Nelson HD, Longton G, Pepe M, Elmore JG.

Arch Pathol Lab Med. 2014 Jul;138(7):955-61. doi: 10.5858/arpa.2013-0263-OA.

7.

Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS).

Oster NV, Carney PA, Allison KH, Weaver DL, Reisch LM, Longton G, Onega T, Pepe M, Geller BM, Nelson HD, Ross TR, Tosteson AN, Elmore JG.

BMC Womens Health. 2013 Feb 5;13:3. doi: 10.1186/1472-6874-13-3.

8.

Testing for improvement in prediction model performance.

Pepe MS, Kerr KF, Longton G, Wang Z.

Stat Med. 2013 Apr 30;32(9):1467-82. doi: 10.1002/sim.5727. Epub 2013 Jan 7.

9.

Estimation and Comparison of Receiver Operating Characteristic Curves.

Pepe M, Longton G, Janes H.

Stata J. 2009 Mar 1;9(1):1.

10.

Accommodating Covariates in ROC Analysis.

Janes H, Longton G, Pepe M.

Stata J. 2009 Jan 1;9(1):17-39.

11.

Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility.

Pepe MS, Feng Z, Longton G, Koopmeiners J.

Stat Med. 2009 Feb 28;28(5):762-79. doi: 10.1002/sim.3506.

12.

TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development.

Grosse-Wilde A, Voloshanenko O, Bailey SL, Longton GM, Schaefer U, Csernok AI, Schütz G, Greiner EF, Kemp CJ, Walczak H.

J Clin Invest. 2008 Jan;118(1):100-10.

13.

Integrating the predictiveness of a marker with its performance as a classifier.

Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, Zheng Y.

Am J Epidemiol. 2008 Feb 1;167(3):362-8. Epub 2007 Nov 2.

14.

p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability.

Payne SR, Zhang S, Tsuchiya K, Moser R, Gurley KE, Longton G, deBoer J, Kemp CJ.

Mol Cell Biol. 2008 Jan;28(1):258-68. Epub 2007 Oct 22.

15.

Computer-assisted mammography feedback program (CAMFP) an electronic tool for continuing medical education.

Urban N, Longton GM, Crowe AD, Drucker MJ, Lehman CD, Peacock S, Lowe KA, Zeliadt SB, Gaul MA.

Acad Radiol. 2007 Sep;14(9):1036-42.

16.

Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables.

Rabinovitch PS, Longton G, Blount PL, Levine DS, Reid BJ.

Am J Gastroenterol. 2001 Nov;96(11):3071-83.

17.

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.

Reid BJ, Prevo LJ, Galipeau PC, Sanchez CA, Longton G, Levine DS, Blount PL, Rabinovitch PS.

Am J Gastroenterol. 2001 Oct;96(10):2839-48.

18.

Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS.

Am J Gastroenterol. 2000 Jul;95(7):1669-76.

19.

Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.

Galipeau PC, Prevo LJ, Sanchez CA, Longton GM, Reid BJ.

J Natl Cancer Inst. 1999 Dec 15;91(24):2087-95.

20.

Definition of HLA-DQ as a transplantation antigen.

Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, Smith AG, Martin PJ, Hansen JA.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15358-63.

Supplemental Content

Loading ...
Support Center